RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 3-Year Clinical Data Continue to Show Superiority of Sirolimus-Eluting versus Bare Metal Stents in STEMI Patients
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 5
SP 10
OP 11
DO 10.1177/155989770700700505
UL http://mdc.sagepub.com/content/7/5/10.abstract
AB Results of 3 years of clinical follow-up data continued to show superiority for a combination of tirofiban+sirolimus-eluting stent (SES) vs a combination of abciximab+bare-metal stent (BMS) in STEMI patients, as evidenced by significantly reduced target vessel revascularization (TVR) rates.